Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary D Hammer

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 15, 2016
Molecular Heterogeneity in Aldosterone-Producing AdenomasKazutaka Nanba, Andrew X Chen, Kei Omata, et al.
Plos One|December 7, 2011
Aged PROP1 deficient dwarf mice maintain ACTH productionIgor O Nasonkin, Robert D Ward, David L Bavers, et al.
World Journal of Surgery|April 25, 2012
Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinomaBarbra S Miller, Kathleen M Ignatoski, Stephanie Daignault, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term resultsGary D Hammer, J Blake Tyrrell, Kathleen R Lamborn, et al.
Development (Cambridge, England)|July 5, 2008
Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortexAlex C Kim, Anne L Reuter, Mohamad Zubair, et al.
Molecular Genetics and Metabolism|March 1, 2006
IMAGe association and congenital adrenal hypoplasia: no disease-causing mutations found in the ACD geneJanna E Hutz, Andrea S Krause, John C Achermann, et al.
Molecular and Cellular Endocrinology|February 10, 2024
Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronismDesmaré van Rooyen, Antonio M Lerario, Donald W Little, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2009
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaPaul Haluska, Frank Worden, David Olmos, et al.
Human Molecular Genetics|November 13, 2004
Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulatorCatherine E Keegan, Janna E Hutz, Tobias Else, et al.
Nature Structural & Molecular Biology|July 17, 2007
Telomere protection by mammalian Pot1 requires interaction with Tpp1Dirk Hockemeyer, Wilhelm Palm, Tobias Else, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Endocrinology and Metabolism|January 15, 2016
Molecular Heterogeneity in Aldosterone-Producing AdenomasKazutaka Nanba, Andrew X Chen, Kei Omata, et al.
Plos One|December 7, 2011
Aged PROP1 deficient dwarf mice maintain ACTH productionIgor O Nasonkin, Robert D Ward, David L Bavers, et al.
World Journal of Surgery|April 25, 2012
Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinomaBarbra S Miller, Kathleen M Ignatoski, Stephanie Daignault, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term resultsGary D Hammer, J Blake Tyrrell, Kathleen R Lamborn, et al.
Development (Cambridge, England)|July 5, 2008
Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortexAlex C Kim, Anne L Reuter, Mohamad Zubair, et al.
Molecular Genetics and Metabolism|March 1, 2006
IMAGe association and congenital adrenal hypoplasia: no disease-causing mutations found in the ACD geneJanna E Hutz, Andrea S Krause, John C Achermann, et al.
Molecular and Cellular Endocrinology|February 10, 2024
Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronismDesmaré van Rooyen, Antonio M Lerario, Donald W Little, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2009
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaPaul Haluska, Frank Worden, David Olmos, et al.
Human Molecular Genetics|November 13, 2004
Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulatorCatherine E Keegan, Janna E Hutz, Tobias Else, et al.
Nature Structural & Molecular Biology|July 17, 2007
Telomere protection by mammalian Pot1 requires interaction with Tpp1Dirk Hockemeyer, Wilhelm Palm, Tobias Else, et al.
Pageof 12